State of California and the University of California are collaborating to improve precise medicine.

The goal of the program is to integrate social data like economic status, genes and clinical data to develop personalized therapies.

The initiative taken by California will enable researchers from across the state to access data from the UC health care system and health care center and other state based academic medical centers.

The program will develop two demonstration projects in the disease area where UC and private partners have expertise.

The data and knowledge required to develop for precision medicine is obtained from the state’s public and private resources. There will be safe, secure and respectful exchange of data between experts from fields of medicine, technology, privacy, intellectual property, bioethics.

Keith Yamamoto, Ph.D., vice chancellor for research at UC San Francisco said, “The success of the California Initiative to Advance Precision Medicine depends upon finding ways to effectively collect and integrate diverse forms of data, from the very objective genomic and molecular to the more subjective environmental influences and life experiences.”

UCSF will host the initiative through UC Health, which includes all the five UC medical centers, by combining $3 billion in state funding with contributions from industry and academic partners.

Governor of California, Jerry Brown and lawmakers has agreed last summer to spend $3 billion for precise medicine from the $156.4 billion state budget that ends June 30.

Atul Butte, director of UCSF’s Institute for Computational Health Sciences, who will lead the program said, “If we can work with interested parties in biotech and Silicon Valley, we’ll have a wealth of resources to develop precision medicine.”

The California’s precise medicine initiative comes after the $215 million precise medicine initiative announced by President Barack Obama in January, which will create a volunteer bank of medical data and tissue samples from patients.